Curve Biosciences, the Whole-Body Intelligence™ company, today announced its Scientific Advisory Board (SAB), bringing together internationally recognized leaders in AI, genomics, and translational medicine.
The SAB is chaired by Shan Wang, Ph.D., Chief Innovation Officer and Co-Founder of Curve Biosciences and Leland T. Edwards Professor in the School of Engineering at Stanford University. The SAB includes experts across industry and academia who guide Curve’s Whole-Body Intelligence platform for biological monitoring of chronic diseases.
“Our Scientific Advisory Board reflects both the magnitude of the opportunity in chronic disease monitoring and the ambition of what we’re building at Curve with Whole-Body Intelligence,” said Ritish Patnaik, Ph.D., CEO and Co-Founder of Curve Biosciences. “These experts have shaped important advances in artificial intelligence, genomics, and precision medicine over the last two decades. Their guidance has been invaluable as we transform how chronic diseases are biologically monitored and ultimately managed.”
The Scientific Advisory Board includes:
Russ Altman, M.D., Ph.D., Kenneth Fong Professor of Bioengineering, Genetics, Medicine, and Biomedical Data Science at Stanford University and Co-Founder of Personalis, Inc. Leading expert in biomedical informatics and healthcare AI.
Kim Clark-Langone, Ph.D., Senior Vice President (SVP) of R&D at Fellow, former VP of Product Development at CareDx, and former scientific leader at Exact Sciences (Genomic Health). Leading expert in genomic tests for personalized medicine.
Kristin Gleitsman, Ph.D., Chief Scientific Officer (CSO) at Eigen Bio, former VP of Discovery Research at Veracyte, and former scientific leader at Guardant Health. Leading expert in integrating AI with genomics for biological discovery platforms.
Imran Haque, Ph.D., Chief Technology Officer at Kimia Therapeutics, former SVP of AI and Digital Sciences at Recursion, and former CSO of Freenome. Leading expert in computational biology with expertise in AI, epigenetics, and structural biology.
Styrmir Sigurjonsson, Ph.D., Former SVP of R&D at Natera, where he delivered key technical and commercial milestones for Signatera, the leading MRD test for oncology. Leading expert in data science, statistics, and bioinformatics applied to healthcare.
Shan Wang, Ph.D. (SAB Chair), Chief Innovation Officer and Co-Founder at Curve Biosciences and Leland T. Edwards Professor in the School of Engineering at Stanford University. Inventor of Whole-Body Intelligence with 360+ publications and 80+ patents.
Peter Washington, Ph.D., Assistant Professor of Clinical Informatics at University of California, San Francisco (UCSF) and a leader in AI, digital health diagnostics, and health monitoring tools using digital data streams.
Wendy Winckler, Ph.D., CSO at Droplet Biosciences, former CSO at Glympse Bio, and former scientific leader at Novartis and the Broad Institute. Leading expert in developing genomic tests with applications for pharmaceutical companies and clinical trials.
James Zou, Ph.D., Associate Professor of Biomedical Data Science at Stanford University and former scientific leader at Microsoft Research. Leading expert in reliable, human-compatible, and statistically rigorous AI for human health and disease.
“Curve is unlocking deep biological insights in blood to transform how chronic diseases are monitored. I am excited to work with this distinguished group of experts to guide the company’s scientific strategy and product roadmap,” said Shan Wang, Ph.D., Chair of the SAB, Chief Innovation Officer and Co-Founder of Curve Biosciences, and Leland T. Edwards Professor in the School of Engineering at Stanford University.
The SAB guides Curve on how to use its Whole-Body Intelligence platform to build its AI moat with its Whole-Body Atlas™ and accelerate development of its Whole-Body Blood Tests™, which are designed to improve chronic disease monitoring and management.
About Curve Biosciences
Curve Biosciences® is the Whole-Body Intelligence company. Curve has created the first molecular blueprint of the human body by manually curating the world’s largest collection of comprehensively-characterized tissue samples into its Whole-Body Atlas. Trained on the clarity of this atlas, the company’s Whole-Body Intelligence models identify chronic disease states through its Whole-Body Blood Tests earlier and more accurately than other methods. Curve’s mission is to provide doctors the best intelligence for their patients and to alleviate the pain of chronic diseases by anchoring medicine in biological truth. The company is based in San Mateo, CA and Dallas, TX. For more information, visit www.curvebio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260609869688/en/
Media gallery
